1
|
Foulkes WD, Smith IE and Reis-Filho JS:
Triple-negative breast cancer. N Engl J Med. 363:1938–1948. 2010.
View Article : Google Scholar : PubMed/NCBI
|
2
|
de Ruijter TC, Veeck J, de Hoon JP, van
Engeland M and Tjan-Heijnen VC: Characteristics of triple-negative
breast cancer. J Cancer Res Clin Oncol. 137:183–192. 2011.
View Article : Google Scholar :
|
3
|
Rakha EA and Chan S: Metastatic
triple-negative breast cancer. Clin Oncol (R Coll Radiol).
23:587–600. 2011. View Article : Google Scholar
|
4
|
Macias H and Hinck L: Mammary gland
development. Wiley Interdiscip Rev Dev Biol. 1:533–557. 2012.
View Article : Google Scholar : PubMed/NCBI
|
5
|
Kuhl H and Schneider HP: Progesterone -
promoter or inhibitor of breast cancer. Climacteric. 16(Suppl 1):
54–68. 2013. View Article : Google Scholar
|
6
|
Axlund SD and Sartorius CA: Progesterone
regulation of stem and progenitor cells in normal and malignant
breast. Mol Cell Endocrinol. 357:71–79. 2012. View Article : Google Scholar :
|
7
|
Lydon JP, Ge G, Kittrell FS, Medina D and
O'Malley BW: Murine mammary gland carcinogenesis is critically
dependent on progesterone receptor function. Cancer Res.
59:4276–4284. 1999.PubMed/NCBI
|
8
|
Obr AE and Edwards DP: The biology of
progesterone receptor in the normal mammary gland and in breast
cancer. Mol Cell Endocrinol. 357:4–17. 2012. View Article : Google Scholar :
|
9
|
Yersal O and Barutca S: Biological
subtypes of breast cancer: prognostic and therapeutic implications.
World J Clin Oncol. 5:412–424. 2014. View Article : Google Scholar : PubMed/NCBI
|
10
|
Shah R, Rosso K and Nathanson SD:
Pathogenesis, prevention, diagnosis and treatment of breast cancer.
World J Clin Oncol. 5:283–298. 2014. View Article : Google Scholar : PubMed/NCBI
|
11
|
Zhu Y, Rice CD, Pang Y, Pace M and Thomas
P: Cloning, expression, and characterization of a membrane
progestin receptor and evidence it is an intermediary in meiotic
maturation of fish oocytes. Proc Natl Acad Sci USA. 100:2231–2236.
2003. View Article : Google Scholar : PubMed/NCBI
|
12
|
Zhu Y, Bond J and Thomas P:
Identification, classification, and partial characterization of
genes in humans and other vertebrates homologous to a fish membrane
progestin receptor. Proc Natl Acad Sci USA. 100:2237–2242. 2003.
View Article : Google Scholar : PubMed/NCBI
|
13
|
Chapman NR, Kennelly MM, Harper KA,
Europe-Finner GN and Robson SC: Examining the spatio-temporal
expression of mRNA encoding the membrane-bound progesterone
receptor-alpha isoform in human cervix and myometrium during
pregnancy and labour. Mol Hum Reprod. 12:19–24. 2006. View Article : Google Scholar : PubMed/NCBI
|
14
|
Dosiou C, Hamilton AE, Pang Y, Overgaard
MT, Tulac S, Dong J, Thomas P and Giudice LC: Expression of
membrane progesterone receptors on human T lymphocytes and Jurkat
cells and activation of G-proteins by progesterone. J Endocrinol.
196:67–77. 2008. View Article : Google Scholar : PubMed/NCBI
|
15
|
Dressing GE and Thomas P: Identification
of membrane progestin receptors in human breast cancer cell lines
and biopsies and their potential involvement in breast cancer.
Steroids. 72:111–116. 2007. View Article : Google Scholar
|
16
|
Fernandes MS, Pierron V, Michalovich D,
Astle S, Thornton S, Peltoketo H, Lam EW, Gellersen B, Huhtaniemi
I, Allen J, et al: Regulated expression of putative membrane
progestin receptor homologues in human endometrium and gestational
tissues. J Endocrinol. 187:89–101. 2005. View Article : Google Scholar : PubMed/NCBI
|
17
|
Karteris E, Zervou S, Pang Y, Dong J,
Hillhouse EW, Randeva HS and Thomas P: Progesterone signaling in
human myometrium through two novel membrane G protein-coupled
receptors: potential role in functional progesterone withdrawal at
term. Mol Endocrinol. 20:1519–1534. 2006. View Article : Google Scholar : PubMed/NCBI
|
18
|
Dressing GE, Alyea R, Pang Y and Thomas P:
Membrane progesterone receptors (mPRs) mediate progestin induced
antimorbidity in breast cancer cells and are expressed in human
breast tumors. Horm Cancer. 3:101–112. 2012. View Article : Google Scholar : PubMed/NCBI
|
19
|
Zuo L, Li W and You S: Progesterone
reverses the mesenchymal phenotypes of basal phenotype breast
cancer cells via a membrane progesterone receptor mediated pathway.
Breast Cancer Res. 12:R342010. View
Article : Google Scholar : PubMed/NCBI
|
20
|
Dai D, Wolf DM, Litman ES, White MJ and
Leslie KK: Progesterone inhibits human endometrial cancer cell
growth and invasiveness: down-regulation of cellular adhesion
molecules through progesterone B receptors. Cancer Res. 62:881–886.
2002.PubMed/NCBI
|
21
|
Thomas P: Characteristics of membrane
progestin receptor alpha (mPRalpha) and progesterone membrane
receptor component 1 (PGMRC1) and their roles in mediating rapid
progestin actions. Front Neuroendocrinol. 29:292–312. 2008.
View Article : Google Scholar : PubMed/NCBI
|
22
|
Sleiter N, Pang Y, Park C, Horton TH, Dong
J, Thomas P and Levine JE: Progesterone receptor A (PRA) and
PRB-independent effects of progesterone on gonadotropin-releasing
hormone release. Endocrinology. 150:3833–3844. 2009. View Article : Google Scholar : PubMed/NCBI
|
23
|
Tubbs C and Thomas P: Progestin signaling
through an olfactory G protein and membrane progestin
receptor-alpha in atlantic croaker sperm: potential role in
induction of sperm hypermotility. Endocrinology. 150:473–484. 2009.
View Article : Google Scholar
|
24
|
Xie M, Zhu X, Liu Z, Shrubsole M, Varma V,
Mayer IA, Dai Q, Chen Q and You S: Membrane progesterone receptor
alpha as a potential prognostic biomarker for breast cancer
survival: a retrospective study. PLoS One. 7:e351982012. View Article : Google Scholar : PubMed/NCBI
|